| Pharmaceutical Preparation |
Labelled Amount (mg) |
Found Amount (mg)a |
Calibration curve
Method |
Standard addition
Method |
| Lazithro tablets b |
250 |
249.7 ± 2.7 |
247.6 ± 3.4 |
| Azee tablets c |
250 |
260.7 ± 6.9 |
249.3 ± 1.1 |
| AzithralLiquidd |
20 |
20.2 ± 1.2 |
21.1 ± 1.8 |
| Phexincapsulese |
500 |
493.1 ± 3.0 |
499.1 ± 5.9 |
| Cefftabletsf |
250 |
247.6 ± 3.0 |
251.7 ± 1.9 |
| Phexin oral suspensiong |
250 |
254.5 ± 1.6 |
245.2 ± 2.7 |
|
a(Avg ± SD) of three determinations
bLesanto laboratories
cCipla Pharmaceuticals
dAlembic Pharmaceutical Limited
e,g GlaxoSmithKline Limited
f Lupin Limited |
| Table 6: Analysis of pharmaceutical formulations. |